RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 6
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Specialist | Memphis, TN | $61.94 | 2 |
| , MBBS | Internal Medicine | Beeville, TX | $61.71 | 3 |
| , MD | Internal Medicine | Eatontown, NJ | $61.62 | 3 |
| Anwar Al-Haidary | Nephrology | Wilson, NC | $61.39 | 4 |
| Christopher Enoch | — | Youngstown, OH | $61.37 | 3 |
| , M.D | Specialist | Memphis, TN | $61.12 | 2 |
| , M.D | Specialist | Houston, TX | $61.04 | 3 |
| , M.D | Nephrology | Terre Haute, IN | $60.95 | 4 |
| , M.D | Internal Medicine | Orangeburg, SC | $60.83 | 4 |
| , M.D | Internal Medicine | San Juan, PR | $60.50 | 3 |
| , M.D | Student in an Organized Health Care Education/Training Program | Memphis, TN | $60.18 | 3 |
| , MD | Nephrology | Flowood, MS | $60.13 | 4 |
| , M.D | Nephrology | Dayton, OH | $59.72 | 4 |
| , M.D | Specialist | Lufkin, TX | $59.63 | 4 |
| , D.O | Nephrology | Yuma, AZ | $59.49 | 3 |
| , MD | Nephrology | Richmond, VA | $59.23 | 3 |
| , MD | Nephrology | Richmond, VA | $59.23 | 3 |
| , MD | Nephrology | Salinas, CA | $59.02 | 3 |
| , M.D | Nephrology | Charleston, SC | $58.99 | 4 |
| , MD | Internal Medicine | San Jose, CA | $58.84 | 3 |
| , M.D | Nephrology | Dallas, TX | $58.60 | 3 |
| , M.D | Specialist | Mobile, AL | $58.48 | 3 |
| , MD | Internal Medicine | Newburgh, NY | $58.31 | 3 |
| , MD | Internal Medicine | Del Rio, TX | $58.26 | 3 |
| , M.D | Nephrology | Houston, TX | $58.08 | 3 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).